Publications
A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.
PubMed
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma. Pubmed
An immunogenic personal neoantigen vaccine for patients with melanoma.. Pubmed
Biomanufacturing for clinically advanced cell therapies. Pubmed
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy. Pubmed
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation. Pubmed
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma. Pubmed
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Pubmed
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation. Pubmed
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Pubmed
Global perspective on the development of genetically modified immune cells for cancer therapy. Pubmed
Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease. Pubmed
Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease. Pubmed
Comparative analysis of cell therapy infusion workflows at clinical sites. Pubmed
PubMed
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma. Pubmed
An immunogenic personal neoantigen vaccine for patients with melanoma.. Pubmed
Biomanufacturing for clinically advanced cell therapies. Pubmed
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy. Pubmed
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation. Pubmed
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma. Pubmed
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Pubmed
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation. Pubmed
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Pubmed
Global perspective on the development of genetically modified immune cells for cancer therapy. Pubmed
Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease. Pubmed
Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease. Pubmed
Comparative analysis of cell therapy infusion workflows at clinical sites. Pubmed